These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34590153)

  • 1. Cholesterol biosynthesis inhibitor RO 48‑8071 inhibits pancreatic ductal adenocarcinoma cell viability by deactivating the JNK and ERK/MAPK signaling pathway.
    Ding Z; Gu Y; Huang D; Zhou H; Zhu T; Luo X; Zhang S; Zhang S; Qian Y
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34590153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.
    Liu L; Qi Y; Huang D; Xu Y; Li M; Hong Z; Gu Y; Jia B; Luo X; Zhang S; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.
    Shankar S; Marsh L; Srivastava RK
    Mol Cell Biochem; 2013 Jan; 372(1-2):83-94. PubMed ID: 22971992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.
    Sano M; Ichimaru Y; Kurita M; Hayashi E; Homma T; Saito H; Masuda S; Nemoto N; Hemmi A; Suzuki T; Miyairi S; Hao H
    Cancer Lett; 2017 Jul; 397():72-82. PubMed ID: 28347789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The JNK Signaling Pathway Is a Novel Molecular Target for S-Propargyl- L-Cysteine, a Naturally-Occurring Garlic Derivatives: Link to Its Anticancer Activity in Pancreatic Cancer In Vitro and In Vivo.
    Wang W; Cheng J; Zhu Y
    Curr Cancer Drug Targets; 2015; 15(7):613-23. PubMed ID: 26033085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human amniotic fluid mesenchymal stem cells attenuate pancreatic cancer cell proliferation and tumor growth in an orthotopic xenograft mouse model.
    Chen YC; Lan YW; Huang SM; Yen CC; Chen W; Wu WJ; Staniczek T; Chong KY; Chen CM
    Stem Cell Res Ther; 2022 Jun; 13(1):235. PubMed ID: 35659367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways.
    Liu Y; Bi T; Wang G; Dai W; Wu G; Qian L; Gao Q; Shen G
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Mar; 388(3):295-304. PubMed ID: 25418891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex.
    Wei H; Wang F; Wang Y; Li T; Xiu P; Zhong J; Sun X; Li J
    Cancer Sci; 2017 Mar; 108(3):478-487. PubMed ID: 28002618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of insulin on human pancreatic cancer progression modeled in vitro.
    Chan MT; Lim GE; Skovsø S; Yang YH; Albrecht T; Alejandro EU; Hoesli CA; Piret JM; Warnock GL; Johnson JD
    BMC Cancer; 2014 Nov; 14():814. PubMed ID: 25373319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma.
    Zhang M; Fan HY; Li SC
    Biomed Pharmacother; 2015 Jul; 73():123-8. PubMed ID: 26211592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth.
    Kurenova E; Liao J; He DH; Hunt D; Yemma M; Bshara W; Seshadri M; Cance WG
    Oncotarget; 2013 Oct; 4(10):1632-46. PubMed ID: 24142503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071.
    Liang Y; Besch-Williford C; Aebi JD; Mafuvadze B; Cook MT; Zou X; Hyder SM
    Breast Cancer Res Treat; 2014 Jul; 146(1):51-62. PubMed ID: 24878988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
    Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
    Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer.
    Guo X; Hollander L; MacPherson D; Wang L; Velazquez H; Chang J; Safirstein R; Cha C; Gorelick F; Desir GV
    Sci Rep; 2016 Mar; 6():22996. PubMed ID: 26972355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moscatilin induces apoptosis of pancreatic cancer cells via reactive oxygen species and the JNK/SAPK pathway.
    Zhang L; Fang Y; Xu XF; Jin DY
    Mol Med Rep; 2017 Mar; 15(3):1195-1203. PubMed ID: 28138710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cordycepin inhibits pancreatic cancer cell growth in vitro and in vivo via targeting FGFR2 and blocking ERK signaling.
    Li XY; Tao H; Jin C; DU ZY; Liao WF; Tang QJ; Ding K
    Chin J Nat Med; 2020 May; 18(5):345-355. PubMed ID: 32451092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis.
    Hung WC; Lee DY; Chiang EI; Syu JN; Chao CY; Yang MD; Tsai SY; Tang FY
    PLoS One; 2020; 15(11):e0241186. PubMed ID: 33137095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth.
    Liang Y; Besch-Williford C; Hyder SM
    Breast Cancer Res Treat; 2022 Feb; 192(1):53-63. PubMed ID: 35037188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis.
    Yan Z; Ohuchida K; Fei S; Zheng B; Guan W; Feng H; Kibe S; Ando Y; Koikawa K; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Hashizume M; Nakamura M
    J Exp Clin Cancer Res; 2019 May; 38(1):221. PubMed ID: 31133044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.